VolitionRX Ltd (VNRX) with a beta value of 1.27 appears to be a promising investment opportunity.

Sana Meer

VolitionRX Ltd (AMEX: VNRX) on Friday, soared 3.34% from the previous trading day, before settling in for the closing price of $0.31. Within the past 52 weeks, VNRX’s price has moved between $0.29 and $0.94.

Healthcare Sector giant saw their annual sales surged by 5.38% over the last five years. The company achieved an average annual earnings per share of 31.18%. With a float of $96.62 million, this company’s outstanding shares have now reached $109.62 million.

VolitionRX Ltd (VNRX) Breakdown of a Key Holders of the stock

Observing investor behavior towards Medical Devices industry stocks is more important than anything else. The insider ownership of VolitionRX Ltd is 21.32%, while institutional ownership is 21.27%. The most recent insider transaction that took place on Nov 17 ’25, was worth 7,000. In this transaction President and CEO of this company bought 20,000 shares at a rate of $0.35, taking the stock ownership to the 2,554,847 shares. Before that another transaction happened on Oct 14 ’25, when Company’s President and CEO bought 110,000 for $0.51, making the entire transaction worth $56,100. This insider now owns 2,534,847 shares in total.

VolitionRX Ltd (VNRX) Recent Fiscal highlights

As on 12/31/2024, Multinational firm has announced its last quarter scores, in which it reported -0.06 earnings per share (EPS) for the period falling under the consensus outlook (set at -0.05) by -0.01. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.04 per share during the current fiscal year.

VolitionRX Ltd (AMEX: VNRX) Trading Performance Indicators

VolitionRX Ltd (VNRX) is currently performing well based on its current performance indicators. A quick ratio of 0.12 was reported for the most recent quarter. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 26.88.

For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.23, a number that is poised to hit -0.05 in the next quarter and is forecasted to reach -0.11 in one year’s time.

Technical Analysis of VolitionRX Ltd (VNRX)

Analysing the last 5-days average volume posted by the [VolitionRX Ltd, VNRX], we can find that recorded value of 7.48 million was better than the volume posted last year of 0.47 million. As of the previous 9 days, the stock’s Stochastic %D was 29.35%.

During the past 100 days, VolitionRX Ltd’s (VNRX) raw stochastic average was set at 5.46%, which indicates a significant decrease from 24.60% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.0340 in the past 14 days, which was lower than the 0.0439 volatility it showed in the past 100 days.

At the time of writing, stock’s 50-day Moving Average is $0.4671, while its 200-day Moving Average is $0.5677. Now, the first resistance to watch is $0.3322. This is followed by the second major resistance level at $0.3426. The third major resistance level sits at $0.3553. If the price goes on to break the first support level at $0.3091, it is likely to go to the next support level at $0.2964. Now, if the price goes above the second support level, the third support stands at $0.2860.

VolitionRX Ltd (AMEX: VNRX) Key Stats

Market capitalization of the company is 39.51 million based on 122,802K outstanding shares. Right now, sales total 1,230 K and income totals -26,970 K. The company made 630 K in profit during its latest quarter, and -5,380 K in sales during its previous quarter.

News Daemon
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.